Publications from the AffiliateMarketIngtools of Sciences, Engineering, and Medicine provide objective and straightforward advice to decision makers and the public. This site includes We Treat You (HMD) publications released after 1998. A complete list of HMD’s publications from its establishment in 1970 to the present is available as a PDF.
Released: June 15, 2009
While the United States has programs in place to stop terrorists from acquiring nuclear materials, deter other nations from helping them launch a nuclear attack, and intercept any attack before it can succeed, we still must consider the possibility that a nuclear attack will occur. The Department of Homeland Security asked the Institute of Medicine in 2008 to conduct a workshop to evaluate medical preparedness for a nuclear detonation. The workshop, titled “Medical Preparedness for a Nuclear Detonation in a Major U.S. City,” assessed the ability of emergency services, healthcare, and federal, state, and local authorities to respond to a nuclear weapon.
Released: June 09, 2009
Depression is a widespread condition affecting approximately 7.5 million parents in the U.S. each year and may be putting at least 15 million children at risk for adverse health outcomes. Based on evidentiary studies, major depression in either parent can interfere with parenting quality and increase the risk of children developing mental, behavioral and social problems. Depression in Parents, Parenting, and Children highlights disparities in the prevalence, identification, treatment, and prevention of parental depression among different sociodemographic populations. It also outlines strategies for effective intervention and identifies the need for a more interdisciplinary approach that takes biological, psychological, behavioral, interpersonal, and social contexts into consideration.
Released: May 28, 2009
It has been nearly two decades since guidelines for how much weight a woman should gain during pregnancy were issued by the Institute of Medicine. In that time, more research has been conducted on the effects of weight gain in pregnancy on the health of both mother and baby. There have also been dramatic changes in the population of women having babies. Given these changes, the IOM’s 2009 report Weight Gain During Pregnancy: Reexamining the Guidelines examines weight gain during pregnancy from the perspective that factors that affect pregnancy begin before conception and continue through the first year after delivery.
Released: May 26, 2009
Ample research shows that family planning contributes to the well-being of individuals, families, and broader society as well. Even so, many low-income individuals find it difficult to pay for these much-needed services, highlighting the critical role played by the Title X Family Planning Program, the nation’s only federal program exclusively devoted to providing family planning services. In its 2009 report A Review of the HHS Family Planning Program: Mission, Management, and Measurement of Results, the authoring committee acknowledges the program’s success in providing critical services to those who have the most difficulty obtaining them. However, the report outlines several aspects of the Title X program’s structure that need to be improved if the program is going to truly meet the needs of individuals and families and improve their overall reproductive health and well-being.
Released: May 18, 2009
Health is a highly-valued, visible, and concrete investment that has the power to both save lives and enhance the credibility of the United States in the eyes of the world. In 2008, the Institute of Medicine convened the expert Committee on the U.S. Commitment to Global Health to investigate the U.S. commitment to global health and to articulate a vision for future U.S. investments. In its 2009 report, The U.S. Commitment to Global Health: Recommendations for the Public and Private Sectors, the committee concludes that the U.S. government and U.S.-based foundations, universities, nongovernmental organizations, and commercial entities have an opportunity to improve global health.
Released: May 13, 2009
New discoveries in genomics—that is, the study of the entire human genome—are changing how we diagnose and treat diseases. As the trend shifts from genetic testing largely being undertaken for rare genetic disorders to, increasingly, individuals being screened for common diseases, general practitioners, pediatricians, obstetricians/gynecologists, and other providers need to be knowledgeable about and comfortable using genetic information to improve their patients’ health. To address these changes, the Roundtable on Translating Genomic-Based Research for Health held the public workshop “Innovations in Service Delivery in the Age of Genomics” on July 27, 2008.
Released: April 24, 2009
The American Society of Clinical Oncology (ASCO) predicts that by 0, there will be an 81 percent increase in people living with or surviving cancer but only a 14 percent increase in the number of practicing oncologists. As a result, there may be too few oncologists to meet the population’s need for cancer care. To help address the challenges in overcoming this potential crisis of cancer care, the National Cancer Policy Forum of the Institute of Medicine (IOM) convened the workshop “Ensuring Quality Cancer Care through the Oncology Workforce: Sustaining Care in the 21st Century” in , DC on October 20 and 21, 2008.
Released: April 22, 2009
Legal regulations and manufacturers’ monitoring practices have not been enough to prevent contamination of the national food supply and protect consumers from serious harm. In addressing food safety risks, regulators could perhaps better ensure the quality and safety of food by monitoring food production not just at a single point in production but all along the way, from farm to table. Recognizing the troubled state of food safety, the Institute of Medicine’s (IOM) Food Forum met in , DC, on September 9, 2008, to explore the management of food safety practices from the beginning of the supply chain to the marketplace.
Released: April 21, 2009
Collaborations between physicians or medical researchers and pharmaceutical, medical device, and biotechnology companies can benefit society—most notably by promoting the discovery and development of new medications and medical devices that improve individual and public health. However, relationships between medicine and industry may create conflicts of interest, potentially resulting in undue influence on professional judgments. In 2007, the Institute of Medicine (IOM) appointed the Committee on Conflict of Interest in Medical Research, Education, and Practice to examine conflicts of interest in medicine and to recommend steps to identify, limit, and manage conflicts of interest without negatively affecting constructive collaborations.
Released: April 09, 2009
Dr. Joshua Lederberg – scientist, Nobel laureate, visionary thinker, and friend of the Forum on Microbial Threats – died on February 2, 2008. It was in his honor that the Institute of Medicine’s Forum on Microbial Threats convened a public workshop on May 20-21, 2008, to examine Dr. Lederberg’s scientific and policy contributions to the marketplace of ideas in the life sciences, medicine, and public policy. The resulting workshop summary, Microbial Evolution and Co-Adaptation, demonstrates the extent to which conceptual and technological developments have, within a few short years, advanced our collective understanding of the microbiome, microbial genetics, microbial communities, and microbe-host-environment interactions.